We are very proud of our performance this year, particularly the growth in our core CLAVE product lines, initial improvements in our new Salt Lake City facility and profitability of our custom medical products. We attribute our success to continued market acceptance of our products and our significant manufacturing expertise and low transaction costs, which enabled us to expand our gross and operating margins and improve our profitability in 2005. Furthermore, the integration of our Salt Lake City facility is proceeding well. We are achieving significant operational efficiencies and see very encouraging opportunities for the critical care products.
|